精神障碍风险与保护因素循证图谱:一项伞状综述
该伞状综述纳入69项系统综述与meta分析(覆盖970项原始研究、221个风险或保护因素),采用标准化分级标准评估各因素与精神病性障碍的关联强度。
要点
- 英格兰黑人非洲裔(OR=4.89)、南亚裔(OR=2.15)及出生体重<2000g(OR=1.77)等6个因素为I级证据。
- 儿童期逆境归因分数最高(40.69%),其次为弓形虫IgG阳性(20.47%)和每周5-7天大麻使用(12.75%)。
核心结论
- 该伞状综述提供了精神病性障碍风险与保护因素的更新循证图谱,支持个体化预后与预防。
- 可干预因素中儿童期逆境、弓形虫IgG阳性及频繁大麻使用的归因分数较高。
研究设计与样本
- 遵循预注册方案,检索Web of Science从2017年2月1日至2025年3月31日发表的观察性研究系统综述与meta分析。
- 纳入69项系统综述与meta分析,报告970项原始研究和221个风险或保护因素。
- 采用国际分类标准将关联证据分为令人信服(I级)、高度提示性(II级)、提示性(III级)和弱(IV级)。
- 进行敏感性分析:将病例数阈值从>1000降至500、限制前瞻性研究、采用Hartung-Knapp-Sidik-Jonkman法。
- 估算可干预I-III级因素的归因分数(PAF),并使用AMSTAR评估研究质量。
主要发现
- I级证据因素包括:英格兰黑人非洲裔(OR=4.89,95%CI:4.04-5.92)、英格兰南亚裔(OR=2.15,95%CI:1.69-2.73)、父亲年龄<20岁(OR=1.34,95%CI:1.20-1.50)、出生体重<2000g(OR=1.77,95%CI:1.48-2.13)、出生体重<2500g(OR=1.50,95%CI:1.38-1.64)、母亲既往妊娠≥3次(OR=1.32,95%CI:1.20-1.45)。
- II级证据因素包括母亲精神病、英格兰黑人加勒比裔、任何母亲精神健康障碍、低种族密度区少数族裔、第一代移民、每周5-7天大麻使用、弓形虫IgG阳性、ADHD史、特质快感缺失、嗅觉识别能力、病前IQ及7项轻微躯体异常相关因素。
- 敏感性分析将临床高危精神病状态(CHR-P)和软神经系统体征从IV级升级为II级。
- 归因分数(PAF)最高为儿童期逆境(40.69%)、弓形虫IgG阳性(20.47%)、每周5-7天大麻使用(12.75%)和CHR-P状态(12.68%)。
关键数值与推荐
- 证据分级标准:令人信服(I级)、高度提示性(II级)、提示性(III级)、弱(IV级)。
- I级因素:英格兰黑人非洲裔OR=4.89(95%CI:4.04-5.92);英格兰南亚裔OR=2.15(95%CI:1.69-2.73);父亲年龄<20岁OR=1.34(95%CI:1.20-1.50);出生体重<2000g OR=1.77(95%CI:1.48-2.13);出生体重<2500g OR=1.50(95%CI:1.38-1.64);母亲既往妊娠≥3次OR=1.32(95%CI:1.20-1.45)。
- PAF:儿童期逆境40.69%;弓形虫IgG阳性20.47%;每周5-7天大麻使用12.75%;CHR-P状态12.68%。
- 平均AMSTAR评分7.73(SD=2.09)。
临床怎么用
- 临床可依据I级和II级证据因素识别精神病高危个体,如特定族裔、低出生体重、父亲年龄过小、母亲精神病史等。
- 针对可干预因素(如儿童期逆境、弓形虫感染、频繁大麻使用)开展预防干预可能降低人群归因风险。
- CHR-P状态和软神经系统体征在敏感性分析中升级为II级证据,提示其在高危评估中的潜在价值。
局限性
- 仅检索Web of Science数据库,可能遗漏其他数据库的研究。
- 纳入的观察性研究存在异质性和混杂可能,证据分级基于meta分析结果。
- 部分因素仅基于少量研究或特定人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Identifying updated, evidence-based risk and protective factors for psychotic disorders is essential to advancing scientific and clinical knowledge of their etiology. Since the most recent umbrella review published in this journal, the evidence base has expanded substantially. Following a pre-registered protocol, we searched the Web of Science for systematic reviews with meta-analyses of observational studies published between the search date of the last umbrella review (February 1, 2017) and March 31, 2025, examining associations of sociodemographic, parental, perinatal, and later factors or antecedents with ICD/DSM (any version) diagnoses of non-organic psychotic disorders. We graded associations between each putative factor and psychotic disorders using standardized international classification criteria: convincing (class I), highly suggestive (class II), suggestive (class III), and weak (class IV). We also conducted sensitivity analyses: a) lowering the classification criterion requiring more than 1,000 cases to 500 cases, b) restricted to prospective studies (class I-II factors), and c) testing more robust estimates of uncertainty (Hartung-Knapp-Sidik-Jonkman method). Then, we estimated the population attributable fraction (PAF) for potentially modifiable class I-III factors. Study quality was assessed with A MeaSurement Tool to Assess systematic Reviews (AMSTAR). A total of 69 systematic reviews and meta-analyses were included, reporting on 970 individual studies and 221 risk or protective factors for psychotic disorders. Six risk factors showed convincing (class I) evidence of association: Black-African ethnicity in England (odds ratio, OR=4.89, 95% CI: 4.04-5.92), South Asian ethnicity in England (OR=2.15, 95% CI: 1.69-2.73), paternal age <20 years (OR=1.34, 95% CI: 1.20-1.50), birthweight under 2,000 g (OR=1.77, 95% CI: 1.48-2.13), birthweight under 2,500 g (OR=1.50, 95% CI: 1.38-1.64), and maternal history of three or more previous pregnancies (OR=1.32, 95% CI: 1.20-1.45). Eighteen additional factors were highly suggestive (class II): maternal psychosis, Black-Caribbean ethnicity in England, any maternal mental health disorder, ethnic minority status in a low ethnic density area, first-generation immigrant status, cannabis use 5 to 7 days per week, Toxoplasma gondii IgG positivity, history of attention-deficit/hyperactivity disorder (ADHD), trait anhedonia, olfactory identification ability, premorbid IQ, and seven factors pertaining to minor physical anomalies. Two additional factors were upgraded from class IV to class II in our sensitivity analyses: clinical high-risk for psychosis (CHR-P) state, and soft neurological signs. Twenty-six factors (including four protective factors) were suggestive (class III), 75 were weak (class IV), and 96 were non-significant. Sensitivity analyses restricted to prospective studies downgraded some of the above factors, but only total minor physical anomalies became non-significant. The largest PAFs (>10%) were found for childhood adversities (40.69%), Toxoplasma gondii IgG positivity (20.47%), cannabis use 5-7 days per week (12.75%), and CHR-P state (12.68%). The sensitivity analyses employing robust uncertainty estimates confirmed that, among class I factors, Black-African ethnicity in England, birthweight under 2,000 g, and birthweight under 2,500 g retained their level of evidence. The mean AMSTAR score was 7.73 (SD=2.09). These findings provide an evidence-based, updated atlas of risk and protective factors for psychosis, advancing epidemiological knowledge, refining precision psychiatry, identifying targets for preventive intervention, and guiding global public health research.
引用
- Aymerich C, De Prisco M, Melillo A, et al. Evidence-based atlas of risk and protective factors for psychotic disorders: an umbrella review to inform personalized prognosis and prevention. World Psychiatry. 2026. PMID: 42742591. doi:10.1002/wps.70093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。